ArticleClinical and experimental nephrology2023

CD4 + and CD8 + T-lymphocyte number as predictive marker of relapse after rituximab treatment in childhood-onset refractory nephrotic syndrome.

Toru Kanamori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.